Anne Lecklin

Ritala-Nurmi, Anneli; Hämeen-Anttila, Katri; Kataja, Antti; Lecklin, Anne; Matikainen, Minna; Palmgren, Joni; Pohjanoksa-Mäntylä, Marika. 2020. #dosisfarma - päivitetyt kirjoitusohjeet, sidonnaisuudet & Dosis-webinaari Dosis 36 1: 3-4. 2020

Vartiainen, Jasmin; Snellman, Viivi; Laukkanen, Eila; Lecklin, Anne. 2020. Näyttö masennuslääkkeiden hyödyistä lapsen ja nuoren masennuksen hoidossa vähäinen Dosis 36 2: 196-215. 2020

Ritala-Nurmi, Anneli; Hämeen-Anttila, Katri; Kataja, Antti; Lecklin, Anne; Matikainen, Minna; Närhi, Ulla; Palmgren, Joni; Pohjanoksa-Mäntylä, Marika. 2018. Open Access Dosis ja uusi toimituskunta [Pääkirjoitus] Dosis 34 1: 5-7. 2018

Puustjärvi Anita, Raunio Hannu, Lecklin Anne, Kumpulainen Kirsti. 2016. Lasten psykiatristen häiriöiden lääkehoito ja tavallisimmat lääkkeet. DUODECIM 132 10: 943-950. 2016

Snellman Viivi, Laukkanen Eila, Lecklin Anne. 2016. Retrospektiivinen tutkimus lääkehoidosta osana laihuushäiriöpotilaiden osastohoitoa. DOSIS : FARMASEUTTINEN AIKAKAUSKIRJA 32 2: 97-108. 2016

Snellman Viivi, Laukkanen Eila, Lecklin Anne. 2016. Syömishäiriöiden psyykenlääkehoidosta tarvitaan lisää tutkimustietoa [Teemat: Psyyke ja lääke]. Sic! Lääketietoa Fimeasta 6 2: 26-29. 2016

Vähärautio Veera, Kononoff Aulikki, Lecklin Anne. 2016. Biologiset lääkkeet osana aikuisten nivelreuman hoitoa. DOSIS : FARMASEUTTINEN AIKAKAUSKIRJA 32 1: 66-74. 2016

Snellman Viivi, Laukkanen Eila, Lecklin Anne. 2015. Psychopharmacology as part of treatment of anorexia nervosa inpatients: a clinical retrospective study. PSYCHIATRIA FENNICA 46: 32-44. 2015

Lecklin Anne. 2014. Biologiset lääkkeet tuovat uusia mahdollisuuksia vaikean nivelreuman hoitoon. NIVELTIETO 2: 9-11. 2014

Raasmaja Atso, Lehtonen Sarka, Kääriäinen Tiina, Lampela Pasi, Huotari Marko, Lecklin Anne. 2013. Tyrosine hydroxylase gene transfections to different sites of striatum in the rat model of Parkinson's disease. Open Journal of Genetics 3: 30-37. 2013

Lecklin Anne. 2013. Miten nivelreumaa hoidetaan tänään? [kuukauden kysymys]. APTEEKKARI: SUOMEN APTEEKKARILEHTI 3/13: 30-33. 2013

Lecklin Anne. 2012. Mitä uutta tyypin 2 diabeteksen hoidossa? [Kuukauden kysymys]. APTEEKKARI: SUOMEN APTEEKKARILEHTI 101 10: 36-37. 2012

Raasmaja Atso, Lecklin Anne, Li Xiang M, Zou Jianqiang, Zhu Guo-Guang, Laakso Into, Hiltunen Raimo. 2012. A water-alcohol extract of Citrus grandis whole fruits has beneficial metabolic effects in the obese Zucker rats fed with high fat/high cholesterol diet. FOOD CHEMISTRY 2013:138: 1392-1399. 2012

Tauriainen Eveliina, Luostarinen Mira, Martonen Essi, Finckenberg Piet, Kovalainen Miia, Huotari Anne, Herzig Karl-Heinz, Lecklin Anne, Mervaala Eero. 2011. Distinct effects of calorie restriction and resveratrol on diet-induced obesity and fatty liver formation Journal of Nutrition and Metabolism 2011: 525094. 2011

Lecklin A. 2010. Mielialantasaajat, epilepsialääkkeet ja paino. DOSIS : FARMASEUTTINEN AIKAKAUSKIRJA 26 4: 232-239. 2010

Lecklin A. 2010. Psykoosi- ja masennuslääkkeet sekä paino. DOSIS : FARMASEUTTINEN AIKAKAUSKIRJA 26 4: 224-231. 2010

Soininen P, Hanzlíková M, Paukkunen M, Lecklin A, Männistö P & Raasmaja A. 2010. Sample purification improves the analysis of nonviral in vivo gene transfection PLASMID 63: 27-30. 2010

Aaltonen N, Palomäki VAB, Lecklin A, Laitinen JT. 2008. Neuroanatomical mapping of juvenile rat brain regions with prominent basal signal in [35S]GTPgammaS autoradiography JOURNAL OF CHEMICAL NEUROANATOMY (AMSTERDAM) 35: 233-241. 2008

Kääriäinen TM, Piltonen M, Ossola B, Kekki H, Lehtonen S, Nenonen T, Lecklin A, Raasmaja A, Männistö PT. 2008. Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures. BRAIN RESEARCH 1203: 149-159. 2008

Boghossian S, Lecklin A, Dube MG, Kalra PS, Kalra SP. 2006. Increased leptin expression in the dorsal vagal complex suppresses adiposity without affecting energy intake and metabolic hormones OBESITY (SILVER SPRING, MD.) 14 6: 1003-1009. 2006

Lecklin A, Dube MG, Torto RN, Kalra PS, Kalra SP. 2005. Perigestational suppression of weight gain with central leptin gene therapy results in lower weight F1 generation. PEPTIDES 26: 1176-1187. 2005

Boghossian S, Lecklin A, Torto R, Kalra PS, Kalra SP. 2005. Suppression of fat deposition for the life time with gene therapy. PEPTIDES 26: 1512-1519. 2005

Lecklin A, Lundell I, Salmela S, Männistö PT, Beck-Sickinger AG, Larhammar D. 2003. Agonists for neuropeptide Y receptors Y1 and Y5 stimulate different phases of feeding in guinea pigs. BRITISH JOURNAL OF PHARMACOLOGY 139: 1433-1440. 2003

Lecklin A, Lundell I, Paananen L, Wikberg JES, Männistö PT, Larhammar D. 2002. Receptor subtypes Y1 and Y5 mediate neuropeptide Y induced feeding in the guinea-pig. BRITISH JOURNAL OF PHARMACOLOGY 135: 2029-2037. 2002

Lecklin A, Tuomisto L. 2002. Inhibition of histamine catabolism suppresses fat intake but not the intake of carbohydrates and protein. INFLAMMATION RESEARCH. SUPPLEMENT 51: 53-54. 2002

Tuomisto L, Lecklin A, Lozeva V, Hippeläinen M, Valtonen M. 2001. Changes in circadian rhythmicity and melatonin balance in rats with portacaval anastomosis (PCA) - relation with histamine: Watanabe T, Timmerman H, Yanai K, Histamine Research in the New Millennium.Elsevier . International Congress Series. 193-198. 2001

Tuomisto L, Lozeva V, Valjakka A, Lecklin A. 2001. Modifying effects of histamine on circadian rhythms and neuronal excitability. BEHAVIOURAL BRAIN RESEARCH 124: 129-135. 2001

Lecklin A, Hermonen P, Tarhanen J, Männistö PT. 2000. An acute i.c.v. infusion of leptin has no effect on hypothalamic histamine and tele-methylhistamine contents in Wistar rats. EUROPEAN JOURNAL OF PHARMACOLOGY 395: 113-119. 2000

Lozeva V, Lecklin A, Valjakka A, Hippeläinen M, Tuomisto L. 2000. Effects of mepyramine on circadian locomotor activity in rats with portacaval anastomosis: Yurdaydin C, Bozkaya H, Advances in Hepatic Encephalopathy & Metabolism in Liver Disease.Turkish Gastroenterology Foundation. 165-169. 2000

Lozeva V, Valjakka A, Lecklin A, Olkkonen H, Hippeläinen M, Itkonen M, Plumed C, Tuomisto L. 2000. Effects of the histamine H1 receptor blocker, pyrilamine, on spontaneous locomotor activity of rats with long-term portacaval anastomosis. HEPATOLOGY 31 2: 336-344. 2000

Lecklin A, Eriksson L, Leppäluoto J, Tarhanen J, Tuomisto L. 1999. Metoprine-induced thirst and diuresis in Wistar rats. ACTA PHYSIOLOGICA (OXFORD) 165: 325-333. 1999

Lecklin A. 1998. Brain Histamine in the Regulation of Food Intake and Body Water Homeostasis in Rats. Kuopion yliopiston julkaisuja A. Farmaseuttiset tieteet. 1998

Lecklin A, Tuomisto L. 1998. The blockade of H1 receptors attenuates the suppression of feeding and diuresis induced by inhibition of histamine catabolism. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 59 3: 753-758. 1998

Lecklin A, Etu-Seppälä P, Stark H, Tuomisto L. 1998. Effects of intracerebroventricularly infused histamine and selective H1, H2 and H3 agonists on food and water intake and urine flow in Wistar rats. BRAIN RESEARCH 793: 279-288. 1998

Konstandi M, Pappas P, Johnson E, Lecklin A, Karageorgou M, Marselos M. 1997. Modification of reproductive function in the rat by 3-methylcholanthrene. PHARMACOLOGICAL RESEARCH 35 2: 107-111. 1997

Konstandi M, Pappas P, Johnson E, Lecklin A, Marselos M. 1997. Suppression of the acquisition of conditioned avoidance behavior in the rat by 3-methylcholanthrene. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 56 4: 637-641. 1997

Lecklin A, Tuomisto L, MacDonald E. 1995. Metoprine, an inhibitor of histamine N-methyltransferase but not catechol-O-methyltransferase, suppresses feeding in sated and in food deprived rats. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY 17: 47-52. 1995

Lecklin A, Tuomisto L. 1995. Fluid balance in rats of three different strains after inhibition of histamine catabolism. PHYSIOLOGY AND BEHAVIOR 58 5: 861-867. 1995

Lecklin A, Järvikylä M, Tuomisto L. 1994. The effect of metoprine on glucoprivic feeding induced by 2-deoxy-D-glucose PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 49 4: 853-857. 1994

Nieminen SA, Sirkka U, Lecklin A, Heikkinen O, Ylitalo P. 1991. Assessment of acute behavioral toxicity of low doses of diisopropylfluorophosphate (DFP) in rats. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY 13 9: 617-623. 1991

Lecklin A, Tuomisto L. 1990. Feed intake after inhibition of histamine catabolism. AGENTS AND ACTIONS 30 1/2: 216-219. 1990

Nieminen SA, Lecklin A, Heikkinen O, Ylitalo P. 1990. Acute behavioural effects of organophosphates sarin and soman in rats PHARMACOLOGY & TOXICOLOGY 67: 36-40. 1990

Airaksinen MM, Lecklin A, Saano V, Tuomisto L, Gynther J. 1987. Tremorigenic Effect and Inhibition of Tryptamine and Serotonin Receptor Binding by beta-Carbolines PHARMACOLOGY & TOXICOLOGY 60: 5-8. 1987

Yhteystiedot

Organisaatio

Sähköposti

Puhelin

Julkaisut